Emergent BioSolutions grants 15,000 RSUs to EVP Jennifer Fox for strategic contributions

Emergent BioSolutions Inc.

Jennifer Fox, EVP External Affairs, General Counsel, and Corporate Secretary, receives 15,000 restricted stock units.
Award vests on first anniversary of grant date, contingent on continued employment.
Special one-time discretionary award approved by Compensation Committee on July 11, 2024.
Award recognizes Fox's substantial contributions to executing recent strategic initiatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.